Article summary
In this secondary analysis of an open-label study of outpatients with treatment-resistant depression, four 0.5 mg/kg ketamine infusions over two weeks were associated with modest decreases in suicidal-ideation items on two depression scales. The Columbia Suicide Severity Rating Scale decrease was not statistically significant, and exploratory plasma-biomarker associations did not survive correction for multiple tests.
Continue to the original publication for the complete article.